Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease
Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate (AT-1001) in Active Celiac Disease
Safety of AT-1001 in Healthy Volunteers
Safety Study of AT1001 to Treat Celiac Disease.
Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Safety and Tolerability Study of AT1001 in Celiac Disease Subjects
† Indicates status has not been verified in more than two years